Finance

Lists
KZIA:NASDAQ
Kazia Therapeutics Ltd
12,31 US$
+1,23%
(+0,15) 1D
12,88 US$
+4,63% (+0,57)
After hours
Closed: 4 სექ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KZIA...
Open
12,00 US$
High
12,62 US$
Low
11,76 US$
Mkt. cap
187,67 მლნ.
Avg. vol.
280,76 ათ.
Volume
414,44 ათ.
52-wk high
17,40 US$
52-wk low
4,86 US$
EPS
-6,52 US$
Beta
2,54
Shares outstanding
15,25 მლნ.
No. of employees
6
Open
12,00 US$
High
12,62 US$
Low
11,76 US$
Mkt. cap
187,67 მლნ.
Avg. vol.
280,76 ათ.
Volume
414,44 ათ.
52-wk high
17,40 US$
52-wk low
4,86 US$
EPS
-6,52 US$
Beta
2,54
Shares outstanding
15,25 მლნ.
No. of employees
6
News stories
From web sources and news partners
About Kazia Therapeutics Ltd
CEO-
Employees6
Founded1994
Headquarters-
Sector-
Websitekaziatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to KZIA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KZIA in the last 3 months.
Highest
Current 12,31 US$
40,00 US$ (+224,94%)
Average
32,75 US$ (+166,04%)
Lowest
29,00 US$ (+135,58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kambiz Yazdi
BTIG
Buy
Reiterated
40,00 US$
+224,9%
09/01/2026
John Newman
Canaccord Genuity
Buy
Reiterated
29,00 US$
+135,6%
09/01/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
29,00 US$
+135,6%
08/13/2026
Naz Rahman
Maxim Group
Buy
Reiterated
30,00 US$
+143,7%
07/15/2026
Chad Messer
Lake Street
Buy
Initiated
32,00 US$
+160%
06/11/2026
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
18,00 US$
+46,2%
06/04/2026
Yale Jen
Laidlaw
Buy
Initiated
25,00 US$
+103,1%
04/15/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
903,36 ათ.
903,36 ათ.
45,96 ათ.
45,96 ათ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 მლნ.
1,52 მლნ.
2,50 მლნ.
2,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,81 მლნ.
1,81 მლნ.
4,28 მლნ.
4,28 მლნ.
Operating expense
3,33 მლნ.
3,33 მლნ.
6,78 მლნ.
6,78 მლნ.
Total operating expenses
3,33 მლნ.
3,33 მლნ.
6,78 მლნ.
6,78 მლნ.
Operating income
-2,42 მლნ.
-2,42 მლნ.
-6,73 მლნ.
-6,73 მლნ.
Other non operating income
-239,18 ათ.
-239,18 ათ.
372,46 ათ.
372,46 ათ.
EBT including unusual items
-5,93 მლნ.
-5,93 მლნ.
-6,28 მლნ.
-6,28 მლნ.
EBT excluding unusual items
-2,64 მლნ.
-2,64 მლნ.
-6,28 მლნ.
-6,28 მლნ.
Income tax expense
-805,23 ათ.
-805,23 ათ.
-
-
Effective tax rate
13,58%
13,58%
-
-
Other operating expenses
-
-
-
-
Net income
-5,12 მლნ.
-5,12 მლნ.
-6,28 მლნ.
-6,28 მლნ.
Net profit margin
-567,23%
-567,23%
-13 655,59%
-13 655,59%
Earnings per share
-
-
-
-
Interest and investment income
21,67 ათ.
21,67 ათ.
80,46 ათ.
80,46 ათ.
Interest expense
-
-
-
-
Net interest expenses
21,67 ათ.
21,67 ათ.
80,46 ათ.
80,46 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,11 მლნ.
-2,19 მლნ.
-6,50 მლნ.
-6,50 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები